anemonin has been researched along with Alloxan Diabetes in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, J; Li, C; Li, T; Liu, Y; Qiao, L | 1 |
1 other study(ies) available for anemonin and Alloxan Diabetes
| Article | Year |
|---|---|
Regulation of iRhom-2/Tumor Necrosis Factor-α Converting Enzyme Pathway and Oxidative Stress Protects the Renal Injury with Anemonin in Streptozotocin-Induced Diabetic Nephropathy Neonatal Rat Model.
Topics: ADAM17 Protein; Animals; Animals, Newborn; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Furans; Intracellular Signaling Peptides and Proteins; Kidney; Oxidative Stress; Protective Agents; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2019 |